# How Viit Health Could Change Everyday Care | Viit Health

- Canonical URL: https://wefunder.com/feed/226447
- Entity ID: wefunder:feed_item:226447
- Published at: 2025-12-02 19:02:23 UTC
- Updated at: 2025-12-03 14:41:41 UTC

## Author
Luis Fernando Gomez

## Subject
Viit Health

## Content
Final Days to Join Our Seed Stage Community RoundWe started Viit Health with a simple belief: preventive care should be effortless, accessible, and grounded in real physiological data. Over the past couple of years, our team and clinical partners have worked with thousands of patients to demonstrate what becomes possible when advanced optical sensing technology is paired with rigorous clinical validation.On November 19, we conducted a full live demonstration of our technology for our investors and medical leaders at UI Health in Chicago. The session included comparative biomarker measurements, real-time signal processing, and a walkthrough of our AI, hardware, and regulatory roadmaps.During the demo, our Viit Gen-3 device produced strong agreement with reference measurements: 95% accuracy for systolic blood pressure 92.4% for diastolic blood pressure 96.4% for heart rate 97.4% for SpO₂ 94.45% for glucose These results reinforced the maturity of our system and confirmed that we are ready to transition toward commercial activation following regulatory approval. Consequently, this validation has allowed us to move forward with closing our Seed Round, and alongside the close, we are now entering the final phase of our WeFunder community raise.What we’re building is not another wellness wearable. It’s a non-invasive, point-of-care healthcare tool that measures multiple biomarkers with clinical accuracy—heart rate, blood pressure, oxygen saturation, glucose, and additional vascular parameters—in 30 seconds using light and AI. Clinics, pharmacies, employers, and community programs can deploy it without needles, complexity, or specialized staff.Over the coming months, we are focused on three key milestones: Finalizing our Viit Gen-4 device to achieve manufacturing readiness. Submitting to COFEPRIS (Mexican regulatory agency) and initiating pilot deployments in Mexico, enabling early revenue generation. Expanding clinical validation in U.S. health systems to support future FDA pathways. These steps lay the foundation for real-world clinical integration and long-term scalability.Our Wefunder round closes on December 12, and there are only a few days left to participate. If you believe, as we do, that preventive care should be simple, scalable, and powered by objective data, we welcome you to join us as we move into this next stage.Help us reshape the future of healthcare!